Business Description
National Research Corp
NAICS : 923120
SIC : 7372
ISIN : US6373722023
Share Class Description:
NRC: Class ADescription
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.18 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 0.75 | |||||
| Debt-to-EBITDA | 0.79 | |||||
| Interest Coverage | 46.51 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 8.43 | |||||
| Beneish M-Score | -2.99 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.1 | |||||
| 3-Year EBITDA Growth Rate | -1.4 | |||||
| 3-Year EPS without NRI Growth Rate | -4.4 | |||||
| 3-Year FCF Growth Rate | -14.1 | |||||
| 3-Year Book Growth Rate | -7.3 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.27 | |||||
| 9-Day RSI | 36.58 | |||||
| 14-Day RSI | 34.76 | |||||
| 6-1 Month Momentum % | -5.72 | |||||
| 12-1 Month Momentum % | -8.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.67 | |||||
| Quick Ratio | 0.67 | |||||
| Cash Ratio | 0.18 | |||||
| Days Sales Outstanding | 33.12 | |||||
| Days Payable | 9.65 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.42 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| 3-Year Dividend Growth Rate | 31.7 | |||||
| Forward Dividend Yield % | 1.42 | |||||
| 5-Year Yield-on-Cost % | 1.37 | |||||
| 3-Year Average Share Buyback Ratio | 1.6 | |||||
| Shareholder Yield % | 3.6 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.3 | |||||
| Operating Margin % | 26.95 | |||||
| Net Margin % | 20.85 | |||||
| FCF Margin % | 15.03 | |||||
| ROE % | 46.75 | |||||
| ROA % | 24.16 | |||||
| ROIC % | 27.03 | |||||
| ROC (Joel Greenblatt) % | 173.4 | |||||
| ROCE % | 44.31 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 27.05 | |||||
| PE Ratio without NRI | 27.05 | |||||
| Shiller PE Ratio | 30.51 | |||||
| Price-to-Owner-Earnings | 28.1 | |||||
| PEG Ratio | 6.29 | |||||
| PS Ratio | 5.61 | |||||
| PB Ratio | 16.73 | |||||
| Price-to-Free-Cash-Flow | 37.32 | |||||
| Price-to-Operating-Cash-Flow | 21.88 | |||||
| EV-to-EBIT | 20.49 | |||||
| EV-to-EBITDA | 17.9 | |||||
| EV-to-Revenue | 5.63 | |||||
| EV-to-FCF | 37.46 | |||||
| Price-to-Projected-FCF | 2.16 | |||||
| Price-to-DCF (Earnings Based) | 1.04 | |||||
| Price-to-DCF (FCF Based) | 3.23 | |||||
| Price-to-Median-PS-Value | 0.8 | |||||
| Earnings Yield (Greenblatt) % | 4.88 | |||||
| FCF Yield % | 2.77 | |||||
| Forward Rate of Return (Yacktman) % | 6.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NRC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
National Research Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 148.58 | ||
| EPS (TTM) ($) | 1.25 | ||
| Beta | 0.27 | ||
| Volatility % | 12.97 | ||
| 14-Day RSI | 34.76 | ||
| 14-Day ATR ($) | 1.030866 | ||
| 20-Day SMA ($) | 35.1555 | ||
| 12-1 Month Momentum % | -8.19 | ||
| 52-Week Range ($) | 32.08 - 47.25 | ||
| Shares Outstanding (Mil) | 23.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
National Research Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
National Research Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
National Research Corp Frequently Asked Questions
What is National Research Corp(NRC)'s stock price today?
The current price of NRC is $33.81. The 52 week high of NRC is $47.25 and 52 week low is $32.08.
When is next earnings date of National Research Corp(NRC)?
The next earnings date of National Research Corp(NRC) is 2024-05-07.
Does National Research Corp(NRC) pay dividends? If so, how much?
The Dividend Yield %  of National Research Corp(NRC) is 1.42% (As of Today), Highest Dividend Payout Ratio of National Research Corp(NRC) was 0.77. The lowest was 0.14. And the median was 0.61. The  Forward Dividend Yield % of National Research Corp(NRC) is 1.42%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers